Want to see SG:9G2 full AI Analyst Report?
Total Valuation
Singapore Institute of Advanced Medicine Holdings Ltd. has a market cap or net worth of S$48.27M. The enterprise value is S$106.62.
Market CapS$48.27M
Enterprise ValueS$106.62
Share Statistics
Singapore Institute of Advanced Medicine Holdings Ltd. has 1,724,092,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,724,092,500
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Singapore Institute of Advanced Medicine Holdings Ltd.’s return on equity (ROE) is -0.45 and return on invested capital (ROIC) is -16.91%.
Return on Equity (ROE)-0.45
Return on Assets (ROA)-0.18
Return on Invested Capital (ROIC)-16.91%
Return on Capital Employed (ROCE)-0.21
Revenue Per Employee149.69K
Profits Per Employee-227.59K
Employee Count105
Asset Turnover0.12
Inventory Turnover11.19
Valuation Ratios
The current PE Ratio of Singapore Institute of Advanced Medicine Holdings Ltd. is ―. Singapore Institute of Advanced Medicine Holdings Ltd.’s PEG ratio is 0.07.
PE Ratio―
PS Ratio2.35
PB Ratio0.70
Price to Fair Value0.70
Price to FCF-8.93
Price to Operating Cash Flow―
PEG Ratio0.07
Income Statement
In the last 12 months, Singapore Institute of Advanced Medicine Holdings Ltd. had revenue of 15.72M and earned -23.90M in profits. Earnings per share was -0.02.
Revenue15.72M
Gross Profit14.50M
Operating Income-20.20M
Pretax Income-23.89M
Net Income-23.90M
EBITDA-8.97M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -5.00M and capital expenditures -611.57K, giving a free cash flow of -5.61M billion.
Operating Cash Flow-5.00M
Free Cash Flow-5.61M
Free Cash Flow per Share>-0.01
Dividends & Yields
Singapore Institute of Advanced Medicine Holdings Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.37
52-Week Price Change-33.33%
50-Day Moving Average0.03
200-Day Moving Average0.04
Relative Strength Index (RSI)47.34
Average Volume (3m)1.23M
Important Dates
Singapore Institute of Advanced Medicine Holdings Ltd. upcoming earnings date is Feb 12, 2027, During Market Hours (Confirmed).
Last Earnings DateAug 29, 2026
Next Earnings DateFeb 12, 2027
Ex-Dividend Date―
Financial Position
Singapore Institute of Advanced Medicine Holdings Ltd. as a current ratio of 0.52, with Debt / Equity ratio of ―
Current Ratio0.52
Quick Ratio0.52
Debt to Market Cap0.80
Net Debt to EBITDA-5.14
Interest Coverage Ratio-4.90
Taxes
In the past 12 months, Singapore Institute of Advanced Medicine Holdings Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Singapore Institute of Advanced Medicine Holdings Ltd. EV to EBITDA ratio is -9.25, with an EV/FCF ratio of -20.08.
EV to Sales5.28
EV to EBITDA-9.25
EV to Free Cash Flow-20.08
EV to Operating Cash Flow-22.77
Balance Sheet
Singapore Institute of Advanced Medicine Holdings Ltd. has S$2.48M in cash and marketable securities with S$61.28M in debt, giving a net cash position of -S$56.14M billion.
Cash & Marketable SecuritiesS$2.48M
Total DebtS$61.28M
Net Cash-S$56.14M
Net Cash Per Share-S$0.03
Tangible Book Value Per ShareS$0.04
Margins
Gross margin is ―, with operating margin of -128.51%, and net profit margin of -152.04%.
Gross Margin―
Operating Margin-128.51%
Pretax Margin-151.97%
Net Profit Margin-152.04%
EBITDA Margin-57.10%
EBIT Margin-125.75%
Analyst Forecast
The average price target for Singapore Institute of Advanced Medicine Holdings Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-1.27%
EPS Growth Forecast16.67%